UNSPSC 85482026: Revision of autologous tissue substitute in peripheral nerve, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in peripheral nerve, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 01WY37Z

UNSPSC 85482026 Revision of autologous tissue substitute in peripheral nerve, percutaneous approach is a Commodity code that does not align with recent state and local procurement activity posted under this classification. The code describes a highly specific surgical procedure for peripheral nerve repair using autologous tissue substitutes, yet the six recent opportunities tagged to it span independent medical evaluations for disability retirement determinations, surgical benefit carve-outs for municipal health plans, occupational medical surveillance, youth detention healthcare services, pharmacy benefit management, and temporary clinical staffing — none involving autologous tissue grafting or surgical nerve procedures. The mismatch suggests either systematic misclassification of these healthcare and benefits administration opportunities or an error in how the code has been applied within the soliciting jurisdictions' procurement systems.

Recent activity under this code reflects municipal human resources departments, county health systems, state transportation agencies, county probation departments, and regional health authorities seeking healthcare administration, benefits management, and clinical staffing support. Geographic distribution across the recent block includes Arizona (Phoenix), California (Long Beach and Santa Clara County), Washington State (Department of Transportation), Texas (Harris County), and Florida (Collier County). The City of Phoenix Retirement Office RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026) and the Washington State Department of Transportation's occupational medical surveillance services RFP (RFP20260825, due October 9, 2026) represent the most concrete recent solicitations, but neither involves the autologous tissue substitute procedure the code nominally describes. Practitioners pursuing work under this code should verify that their actual service offering aligns with the substantive scope posted by the issuing body, as the code's current application appears to be administrative rather than clinically accurate.